Requests that the FDA ensures that any generic version of diazepam nasal spray is no less safe and effective than VALTOCO® for all approved uses that remain on the generic label. | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-7728

Requests that the FDA ensures that any generic version of diazepam nasal spray is no less safe and effective than VALTOCO® for all approved uses that remain on the generic label.

Documents

Comments

Key Dates

Comment Period OpensJul 13, 2026

Documents

Type	Title	Posted	Comments	Status
Supporting Material	Exhibit A	Jul 13, 2026	--

Keywords

CDER

Citizen Petition

Neurelis Inc

ensures that

any generic version of diazepam nasal spray is

no less safe and effective than VALTOCO for all

approved uses that remain on the generic label

OPEN

Data from Regulations.gov